NO20034357D0 - Terapeutisk middel for bl¶reirriterende symptomer forbundet med benign prostatahyperplasi - Google Patents

Terapeutisk middel for bl¶reirriterende symptomer forbundet med benign prostatahyperplasi

Info

Publication number
NO20034357D0
NO20034357D0 NO20034357A NO20034357A NO20034357D0 NO 20034357 D0 NO20034357 D0 NO 20034357D0 NO 20034357 A NO20034357 A NO 20034357A NO 20034357 A NO20034357 A NO 20034357A NO 20034357 D0 NO20034357 D0 NO 20034357D0
Authority
NO
Norway
Prior art keywords
symptoms associated
benign prostatic
prostatic hyperplasia
bladder irritation
irritation symptoms
Prior art date
Application number
NO20034357A
Other languages
English (en)
Other versions
NO20034357L (no
Inventor
Tsuyoshi Yamagata
Kaoru Atsuki
Tetsuji Ohno
Shiro Shirakura
Akira Karasawa
Original Assignee
Kyowa Hakko Kogyo Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Kogyo Kk filed Critical Kyowa Hakko Kogyo Kk
Publication of NO20034357D0 publication Critical patent/NO20034357D0/no
Publication of NO20034357L publication Critical patent/NO20034357L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
NO20034357A 2001-03-30 2003-09-29 Terapeutisk middel for bl¶reirriterende symptomer forbundet med benign prostatahyperplasi NO20034357L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001099799 2001-03-30
PCT/JP2002/003169 WO2002078712A1 (fr) 2001-03-30 2002-03-29 Remedes de stimulation vesicale en association avec une hypertrophie de la prostate

Publications (2)

Publication Number Publication Date
NO20034357D0 true NO20034357D0 (no) 2003-09-29
NO20034357L NO20034357L (no) 2003-11-24

Family

ID=18953302

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20034357A NO20034357L (no) 2001-03-30 2003-09-29 Terapeutisk middel for bl¶reirriterende symptomer forbundet med benign prostatahyperplasi

Country Status (13)

Country Link
US (1) US7354949B2 (no)
EP (1) EP1380299A4 (no)
JP (1) JP4104986B2 (no)
KR (1) KR20040007477A (no)
CN (1) CN1230178C (no)
BR (1) BR0208416A (no)
CA (1) CA2442472A1 (no)
EA (1) EA006448B1 (no)
HK (1) HK1064616A1 (no)
HU (1) HUP0303610A3 (no)
MX (1) MXPA03008815A (no)
NO (1) NO20034357L (no)
WO (1) WO2002078712A1 (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2520680A1 (en) * 2003-03-31 2004-10-14 Kyowa Hakko Kogyo Co., Ltd. Antitussives
TW200501938A (en) * 2003-06-27 2005-01-16 Kyowa Hakko Kogyo Kk A medicament for therapeutic treating overactive urinary bladder accompany with cerebrovascular disorder
EP1652532A1 (en) * 2003-07-16 2006-05-03 Kyowa Hakko Kogyo Co., Ltd. Medicinal composition
JPWO2005007155A1 (ja) * 2003-07-16 2006-08-31 協和醗酵工業株式会社 医薬組成物
TW200522943A (en) * 2003-12-11 2005-07-16 Kyowa Hakko Kogyo Kk Fine crystallites and a pharmaceutical composition comprising them
TW200827367A (en) 2006-10-26 2008-07-01 Kyowa Hakko Kogyo Kk A therapeutic agent for irritable bowel syndrome

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE201195T1 (de) * 1995-10-16 2001-06-15 Kyowa Hakko Kogyo Kk Tricyclische verbindungen
BR9808552A (pt) * 1997-04-15 2000-05-23 Kyowa Hakko Kogyo Kk Composto tricìclico ou um sal farmaceuticamente aceitável do mesmo, e, composição farmacêutica

Also Published As

Publication number Publication date
CN1499974A (zh) 2004-05-26
HUP0303610A2 (hu) 2004-03-01
US20040110784A1 (en) 2004-06-10
EP1380299A1 (en) 2004-01-14
WO2002078712A1 (fr) 2002-10-10
CA2442472A1 (en) 2002-10-10
US7354949B2 (en) 2008-04-08
EA006448B1 (ru) 2005-12-29
HUP0303610A3 (en) 2005-02-28
EP1380299A4 (en) 2009-05-06
BR0208416A (pt) 2004-03-02
NO20034357L (no) 2003-11-24
EA200301078A1 (ru) 2004-02-26
HK1064616A1 (en) 2005-02-04
CN1230178C (zh) 2005-12-07
JP4104986B2 (ja) 2008-06-18
MXPA03008815A (es) 2004-02-17
KR20040007477A (ko) 2004-01-24
JPWO2002078712A1 (ja) 2004-07-22

Similar Documents

Publication Publication Date Title
NO20034176D0 (no) Pyrazolopyrimidiner som terapeutiske midler
NO20034177L (no) Pyrazolopyrimidiner som terapeutiske midler
NO20021328D0 (no) Pyrazolopyrimidiner som terapeutiske midler
AR028285A1 (es) Medicamentos intracorporeos para tratamiento fotodinamico de enfermedad
NO20034166L (no) Molekyl¶re konjugater for anvendelse ved behandling av cancer
DE60125937D1 (de) Wirbelsäulenimplantat für osteosynthesevorrichtung
NO20034590D0 (no) Fremgangsmåter for behandling av vaskul¶r sykdom
NO20026008D0 (no) Fremgangsmåte for behandling av cardiovaskul¶re sykdommer
PT1235558E (pt) Agentes terapeuticos
NO20024775L (no) Hydroksyfenyl-piperidin-4-yliden-metyl-benzamid derivater til behandling avsmerte
IS7444A (is) Morfólínýl-þvagefna afleiður til notkunar við meðhöndlun á bólguvaldandi sjúkdómum
NO20034560D0 (no) Middel for topisk oftalmisk behandling av okul¶re inflammasjonssykdommer
ITNA20000036A0 (it) Nuovi approcci terapeutici per il trattamento della forfora.
NO20034357D0 (no) Terapeutisk middel for bl¶reirriterende symptomer forbundet med benign prostatahyperplasi
HK1085373A1 (en) Compound and use in the manufacture of a medicament for the treatment of benign prostatic hyperplasia and associated symptoms
CY1105814T1 (el) Δαριφενακινη για χρηση στη θεραπεια της επειξης προς ουρηση λογω υπepλειτουργικης ουροδοχου κυστης
PT1268482E (pt) Piranoindois para o tratamento de glaucoma
EE200200605A (et) Asendatud akrüloüüldistamütsiini derivaadi kasutamine ravimi valmistamiseks, mis on ette nähtud glutatiooni kõrge tasemega seotud kasvajate raviks
NO20034358D0 (no) Terapeutisk middel for bl¶rehypersensitivitet
FR2805983B3 (fr) Douche
EP1372639A4 (en) TREATMENT AGENT FOR BLADDER IRRITATION SYMPTOMS ACCOMPANIED WITH BENIGN PROSTATIC HYPERPLASIA
IT1320192B1 (it) Composizione terapeutica per la cura della psoriasi.
NO20032206L (no) Kombinasjonsterapi for östrogen-avhengige forstyrrelser
NO20025760D0 (no) S-metyl-dihydro-ziprasidon for behandling av psykiatriske og okkul¶re forstyrrelser
ES1052847Y (es) Dispositivo para ducha e hidromasaje.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application